✦ LIBER ✦

An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial

✍ Scribed by Cesare Gridelli; Charles Butts; Fortunato Ciardiello; Ronald Feld; Ciro Gallo; Francesco Perrone

Book ID: 115076698
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 91 KB
Volume: 9
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2008.n.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Erlotinib Followed by Second-

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized Trial

✍ Gridelli, C.; Ciardiello, F.; Gallo, C.; Feld, R.; Butts, C.; Gebbia, V.; Maione 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 259 KB

Randomized, Phase III Study of Gemcitabi

Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer

✍ Perol, M.; Chouaid, C.; Perol, D.; Barlesi, F.; Gervais, R.; Westeel, V.; Crequi 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 264 KB

Cisplatin and gemcitabine first-line che

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

✍ Brodowicz, Thomas; Krzakowski, Maciej; Zwitter, Matjaz; Tzekova, Valentina; Raml 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Randomised multicenter phase II study of

Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer

✍ Novello, Silvia; Falcone, Alfredo; Crinò, Lucio; Rinaldi, Massimo; Nardi, Mario; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Docetaxel/gemcitabine or cisplatin/gemci

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

First-line chemotherapy with planned seq

First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly ‘unfrail’ patients with advanced non-small-cell lung cancer: a multicenter phase II study

✍ C. Tibaldi, A. Camerini, A. D’Incecco, E. Vasile, A. Fabbri, D. Amoroso, F. Capp 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 174 KB